Welcome! Our website uses cookies exclusively for usage analytics and reporting metrics to our stakeholders
and funding agencies about site usage. These cookies also help us understand how visitors interact with our
site, enabling us to improve your browsing experience and the content we offer. We respect your privacy and
ensure that all data collected is anonymized and used solely to guide our enhancements. Additionally, we do
not use this data for marketing purposes nor do we share any user information with third parties.
By clicking "Accept," you consent to our use of cookies for these purposes. For more detailed information on
the cookies we use and how we handle your data, please review our Privacy Policy.
Jaxpheno12:
Type 1 diabetes incidence and other phenotypes in NOD/ShiLtJ mice on a 6% fat diet (2018)
Jackson Laboratory
Andrew J Schile
Jaxpheno12 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Institutional authorship
Jackson Laboratory
Investigators
Andrew J Schile The Jackson Laboratory -- West, Sacramento, CA
No updates/corrections.
Initial release date: 02/2018.
Formatted citation
Click above to copy-paste the entire citation for this MPD web page.
Purpose:
To
assess effects relevant to type 1 diabetes in a longitudinal study on NOD/ShiLtJ male and female mice fed a 6% fat diet (LabDiet® 5K52) between the ages of 3 and 30 weeks.Per-animal data are available in the download file.
Methods
One hundred twenty female and eighty male mice were obtained at weaning (birthdate +/- 3 days) from colonies in the Bar Harbor (standard barrier) and Sacramento (maximum barrier) facilities of The Jackson Laboratory. Mice were fed a 6% fat diet (LabDiet® 5K52 formulation), ad libitum. Mice were weighed weekly until 30 weeks of age, on the same day each week. Diabetes onset was also monitored between the ages of 3 and 30 weeks. Diabetes was defined as a non-fasting blood glucose level exceeding 250 mg/dL. Blood was sampled in the morning from the submandibular route and analyzed using a OneTouch Ultra2 or UltraMini handheld glucometer that was validated using a control solution on each measurement day. Data were combined from two independent studies that each included 60 females and 40 males. Median onset was 18 weeks for females and 30 weeks for males (Figure 1). The Kaplan-Meier curves did not differ significantly between the individual studies (conducted in Standard and Maximum barrier rooms). Mice were removed from the study when they became diabetic, developed adverse clinical signs, or were used for phenotyping projects at the ages of 8, 16 and 30 weeks. Mice used for phenotyping were weighed and body composition was analyzed using a Lunar PIXImus DEXA scanner. Calculations of body composition excluded the head. Cardiac blood was collected under isoflurane anesthesia and divided for hematology (using a Siemens Advia 2120 or Drew Scientific Hemavet 950 FS analyzer) or serum biochemistry (Beckman AU680 analyzer). Single-cell suspensions were also analyzed by flow cytometry following a protocol found here.
Available
download (per animal data):
Body weights, blood glucose readings, DXA body composition, spleen flow cytometry, serum clinical chemistry, and hematology.
